Neurotrophic factor treatment after spinal root avulsion injury

Central Nervous System Agents in Medicinal Chemistry

Volumn 9, Issue 1, 2009, Pages 40-55

  Chu, Tak Ho ^a   Wu, Tian ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Avulsion; Brachial plexus injury; Nerve implantation; Neurotrophic factors; Peripheral nerve injury

Indexed keywords

ARTEMIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CARDIOTROPHIN 1; CILIARY NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LENTIVIRUS VECTOR; LEUKEMIA INHIBITORY FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; NEUROTROPHIN 6; NEURTURIN; PERSEPHIN; PLEIOTROPHIN; RILUZOLE; SCATTER FACTOR; SERINE PROTEINASE INHIBITOR; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN;

AMYOTROPHIC LATERAL SCLEROSIS; AVULSION INJURY; CELL DEATH; CELL STRUCTURE; CELL SURVIVAL; CLINICAL TRIAL; CONTINUOUS INFUSION; CONVALESCENCE; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; HUMAN; LAMINECTOMY; MOTONEURON; MUSCLE ATROPHY; NERVE CELL NETWORK; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVE GRAFT; NERVE INJURY; NERVE SURGERY; NEUROPROTECTION; NEUROTROPISM; NONHUMAN; PERIPHERAL NERVE INJURY; PROTEIN EXPRESSION; REVIEW; SCHWANN CELL; SENSORIMOTOR FUNCTION; SINGLE DRUG DOSE; SPINAL CORD MOTONEURON; SPINAL NERVE AVULSION INJURY; SPINAL ROOT; VIRAL GENE DELIVERY SYSTEM;

ACTION POTENTIALS; ANIMALS; BRACHIAL PLEXUS NEUROPATHIES; MOTOR NEURONS; MUSCLE, SKELETAL; NERVE GROWTH FACTORS; NERVE REGENERATION; NEURAL CONDUCTION; NEURONAL PLASTICITY; NEURONS, AFFERENT; PERIPHERAL NERVES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECOVERY OF FUNCTION; REGENERATION; SPINAL CORD; SPINAL CORD INJURIES; SPINAL NERVE ROOTS;

EID: 62549107119     PISSN: 18715249     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152409787601914     Document Type: Review

References (242)

1. Koliatsos V. E.; Price W. L.; Pardo C. A.; Price D. L. Ventral root avulsion: an experimental model of death of adult motor neurons. J. Comp. Neurol., 1994, 342(1), 35-44.
2. Wu W. Expression of nitric-oxide synthase (NOS) in injured CNS neurons as shown by NADPH diaphorase histochemistry. Exp. Neurol., 1993, 720(2), 153-159.
3. Carlstedt T.; Grane P.; Hallin R. G.; Noren G. Return of function after spinal cord implantation of avulsed spinal nerve roots. Lancet, 1995, 346(8986), 1323-1325.
4. Wu W.; Han K.; Li L.; Schinco F. P. Implantation of PNS graft inhibits the induction of neuronal nitric oxide synthase and enhances the survival of spinal motoneurons following root avulsion. Exp. Neurol., 1994, 129(2), 335-339.
5. Carlstedt T.; Cullheim S. Spinal cord motoneuron maintenance, injury and repair. Prog. Brain Res., 2000, 127501-514.
6. Carlstedt T.; Anand P.; Hallin R.; Misra P. V.; Noren G.; Seferlis T. Spinal nerve root repair and reimplantation of avulsed ventral roots into the spinal cord after brachial plexus injury. J. Neurosurg., 2000, 93(2 Suppl), 237-247.
7. Cullheim S.; Wallquist W.; Hammarberg H.; Linda H.; Piehl F.; Carlstedt T.; Risling M. Properties of motoneurons underlying their regenerative capacity after axon lesions in the ventral funiculus or at the surface of the spinal cord. Brain Res. Brain Res. Rev., 2002, 40(1-3), 309-316.
8. Narakas A. O. The treatment of brachial plexus injuries. 7nt. Orthop., 1985, 9(1), 29-36.
9. Terzis J. K.; Vekris M. D.; Soucacos P. N. Brachial plexus root avulsions. World J. Surg., 2001, 25(8), 1049-1061.
10. Dunham E. A. Obstetrical brachial plexus palsy. Orthop. Nurs., 2003, 22(2), 106-116.
11. Midha R. Epidemiology of brachial plexus injuries in a multi-trauma population. Neurosurgery, 1997, 40(6), 1182-1188.
12. Carlstedt T. Approaches permitting and enhancing motoneuron regeneration after spinal cord, ventral root, plexus and peripheral nerve injuries. Curr. Opin. Neurol., 2000, 13(6), 683-686.
13. Midha R. Nerve transfers for severe brachial plexus injuries: a review. Neurosurg. Focus., 2004, 16(5), E5.
14. Doi K.; Muramatsu K.; Hattori Y.; Otsuka K.; Tan S. H.; Nanda V.; Watanabe M. Restoration of prehension with the double free muscle technique following complete avulsion of the brachial plexus. Indications and long-term results. J. Bone Joint Surg. Am., 2000, 82(5), 652-666.
15. Gu Y. D.; Chen D. S.; Zhang G. M.; Cheng X. M.; Xu J. G.; Zhang L. Y.; Cai P. Q.; Chen L. Long-term functional results of contralateral C7 transfer. J. Reconstr. Microsurg., 1998, 14(1), 57-59.
16. Cullheim S.; Carlstedt T.; Linda H.; Risling M.; Ulfhake B. Motoneurons reinnervate skeletal muscle after ventral root implantation into the spinal cord of the cat. Neuroscience, 1989, 29(3), 725-733.
17. Carlstedt T. Functional recovery after ventral root avulsion and implantation in the spinal cord. Clin. Neurol. Neurosurg., 1993, 95 (Suppl), S109-S111.
18. Carlstedt T.; Linda H.; Cullheim S.; Risling M. Reinnervation of hind limb muscles after ventral root avulsion and implantation in the lumbar spinal cord of the adult rat. Acta Physiol. Scand., 1986, 128(4), 645-646.
19. Bertelli J. A.; Ghizoni M. F. Brachial plexus avulsion injury repairs with nerve transfers and nerve grafts directly implanted into the spinal cord yield partial recovery of shoulder and elbow movements. Neurosurgery, 2003, 52(6), 1385-1389.
20. Hsu S. P.; Shih Y. H.; Huang M. C.; Chuang T. Y.; Huang W. C.; Wu H. M.; Lin P. H.; Lee L. S.; Cheng H. Repair of multiple cervical root avulsion with sural nerve graft. Injury, 2004, 35(9), 896-907.
21. Carlstedt T.; Anand P.; Htut M.; Misra P.; Svensson M. Restoration of hand function and so called "breathing arm" after intraspinal repair of C5-T1 brachial plexus avulsion injury. Case report. Neurosurg. Focus., 2004, 16(5), E7.
22. He J. W.; Hirata K.; Kuraoka A.; Kawabuchi M. An improved method for avulsion of lumbar nerve roots as an experimental model of nitric oxide-mediated neuronal degeneration. Brain Res. Brain Res. Protoc., 2000, 5(3), 223-230.
23. Watabe K.; Hayashi Y.; Kawazoe Y. Peripheral nerve avulsion injuries as experimental models for adult motoneuron degeneration. Neuropathology, 2005, 25(4), 371-380.
24. Martin L. J.; Kaiser A.; Price A. C. Motor neuron degeneration after sciatic nerve avulsion in adult rat evolves with oxidative stress and is apoptosis. J. Neurobiol., 1999, 40(2), 185-201.
25. Torvik A.; Soreide A. J. The perineuronal glial reaction after axotomy. Brain Res., 1975, 95(2-3), 519-529.
26. Ruan R. S.; Leong S. K.; Yeoh K. H. The role of nitric oxide in facial motoneuronal death. Brain Res., 1995, 698(1-2), 163-168.
27. Yu W. H. Regulation of nitric oxide synthase expression in motoneurons following nerve injury. Dev. Neurosci., 1997, 19(3), 247-254.
28. Martin L. J.; Chen K.; Liu Z. Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation. J. Neurosci., 2005, 25(27), 6449-6459.
29. Carlstedt T.; Linda H.; Cullheim S.; Risling M. Reinnervation of hind limb muscles after ventral root avulsion and implantation in the lumbar spinal cord of the adult rat. Acta Physiol. Scand., 1986, 128(4), 645-646.
30. Chu, T. H.; Wu, W. Spinal root avulsion and repair model. In animal models of acute neurological injuries. Chen, J.; Xu, X.M.; Xu, Z.C.; Zhang, J., Ed., Chapter 42, Humana Press. 2008.
31. Li L.; Houenou L. J.; Wu W.; Lei M.; Prevette D. M.; Oppenheim R. W. Characterization of spinal motoneuron degeneration following different types of peripheral nerve injury in neonatal and adult mice. J. Comp. Neurol., 1998, 396(2), 158-168.
32. Martin L. J.; Kaiser A.; Price A. C. Motor neuron degeneration after sciatic nerve avulsion in adult rat evolves with oxidative stress and is apoptosis. J. Neurobiol., 1999, 40(2), 185-201.
33. Park O. H.; Lee K. J.; Rhyu I. J.; Geum D.; Kim H.; Buss R.; Oppenheim R. W.; Sun W. Bax-dependent and -independent death of motoneurons after facial nerve injury in adult mice. Eur. J. Neurosci., 2007, 26(6), 1421-1432.
34. Wu W. Response of nitric oxide synthase to neuronal injury. Handbook of Chemical Neuroanatomy, 2000, 17(LX), 315-353.
35. Ohlsson M.; Havton L. A. Complement activation after lumbosacral ventral root avulsion injury. Neurosci. Lett., 2006, 394(3), 179-183.
36. Gu H. Y.; Chai H.; Zhang J. Y.; Yao Z. B.; Zhou L. H.; Wong W. M.; Bruce I.; Wu W. T. Survival, regeneration and functional recovery of motoneurons in adult rats by reimplantation of ventral root following spinal root avulsion. Eur. J. Neurosci., 2004, 19(8), 2123-2131.
37. Linda H.; Cullheim S.; Risling M. A light and electron microscopic study of intracellularly HRP-labeled lumbar motoneurons after intramedullary axotomy in the adult cat. J. Comp. Neurol., 1992, 318(2), 188-208.
38. Linda H.; Shupliakov O.; Ornung G.; Ottersen O. P.; Storm-Mathisen J.; Risling M.; Cullheim S. Ultrastructural evidence for a preferential elimination of glutamate-immunoreactive synaptic terminals from spinal motoneurons after intramedullary axotomy. J. Comp. Neurol., 2000, 425(1), 10-23.
39. Hu J.; Fink D.; Mata M. Microarray analysis suggests the involvement of proteasomes, lysosomes, and matrix metalloproteinases in the response of motor neurons to root avulsion. Eur. J. Neurosci., 2002, 16(8), 1409-1416.
40. Yang Y.; Xie Y.; Chai H.; Fan M.; Liu S.; Liu H.; Bruce I.; Wu W. Microarray analysis of gene expression patterns in adult spinal motoneurons after different types of axonal injuries. Brain Res., 2006, 1075(1), 1-12.
41. Piehl F.; Hammarberg H.; Tabar G.; Hokfelt T.; Cullheim S. Changes in the mRNA expression pattern, with special reference to calcitonin gene-related peptide, after axonal injuries in rat motoneurons depends on age and type of injury. Exp. Brain Res., 1998, 119(2), 191-204.
42. Wu W. Potential roles of gene expression change in adult rat spinal motoneurons following axonal injury: a comparison among c-jun, off-affinity nerve growth factor receptor (LNGFR), and nitric oxide synthase (NOS). Exp. Neurol., 1996, 141 (2), 190-200.
43. Piehl F.; Arvidsson U.; Johnson H.; Cullheim S.; Villar M.; Dagerlind A.; Terenius L.; Hokfelt T.; Ulfhake B. Calcitonin Gene-related Peptide (CGRP)-like immunoreactivity and cgrp mrna in rat spinal cord motoneurons after different types of lesions. Eur. J. Neurosci., 1991, 3(8), 737-757.
44. Piehl F.; Tabar G.; Cullheim S. Expression of NMDA receptor mRNAs in rat motoneurons is down-regulated after axotomy. Eur. J. Neurosci., 1995, 7(10), 2101-2110.
45. Rameau G. A.; Chiu L. Y.; Ziff E. B. NMDA receptor regulation of nNOS phosphorylation and induction of neuron death. Neurobiol. Aging, 2003, 24(8), 1123-1133.
46. He J. W.; Hirata K.; Wang S.; Kawabuchi M. Expression of nitric oxide synthase and 27-kD heat shock protein in motor neurons of ventral root-avulsed rats. Arch. Histol. Cytol., 2003, 66(1), 83-93.
47. Hammarberg H.; Risling M.; Hokfelt T.; Cullheim S.; Piehl F. Expression of insulin-like growth factors and corresponding binding proteins (IGFBP 1-6) in rat spinal cord and peripheral nerve after axonal injuries. J. Comp. Neurol., 1998, 400(1), 57-72.
48. Hammarberg H.; Piehl F.; Risling M.; Cullheim S. Differential regulation of trophic factor receptor mRNAs in spinal motoneurons after sciatic nerve transection and ventral root avulsion in the rat. J. Comp. Neurol., 2000, 426(4), 587-601.
49. Gu Y.; Spasic Z.; Wu W. The effects of remaining axons on motoneuron survival and NOS expression following axotomy in the adult rat. Dev. Neurosci., 1997, 19(3), 255-259.
50. Havton L.; Kellerth J. O. Regeneration by supernumerary axons with synaptic terminals in spinal motoneurons of cats. Nature, 1987, 325(6106), 711-714.
51. Linda H.; Risling M.; Cullheim S. 'Dendraxons' in regenerating motoneurons in the cat: do dendrites generate new axons after central axotomy? Brain Res., 1985, 358(1-2), 329-333.
52. Li Y.; Raisman G. Schwann cells induce sprouting in motor and sensory axons in the adult rat spinal cord. J. Neurosci., 1994, 14(7), 4050-4063.
53. Frostick S. P.; Yin Q.; Kemp G. J. Schwann cells, neurotrophic factors, and peripheral nerve regeneration. Microsurgery, 1998, 18(7), 397-405.
54. Ekestern E. Neurotrophic factors and amyotrophic lateral sclerosis. Neurodegener. Dis., 2004, 1(2-3), 88-100.
55. Risling M.; Sorbye K.; Cullheim S. Aberrant regeneration of motor axons into the pia mater after ventral root neuroma formation. Brain Res., 1992, 570(1-2), 27-34.
56. Risling M.; Hildebrand C.; Cullheim S. Invasion of the L7 ventral root and spinal pia mater by new axons after sciatic nerve division in kittens. Exp. Neurol., 1984, 83(1), 84-97.
57. Carlstedt T. Nerve fibre regeneration across the peripheral-central transitional zone. J. Anat., 1997, 190 ( Pt 1)51-56.
58. Brushart T. M. Neurotropism and neurotrophism. J. Hand Surg., 1987, 12A808-.
59. Cullheim S.; Carlstedt T.; Linda H.; Risling M.; Ulfhake B. Motoneurons reinnervate skeletal muscle after ventral root implantation into the spinal cord of the cat. Neuroscience, 1989, 29(3), 725-73.
60. Carlstedt T. P.; Hallin R. G.; Hedstrom K. G.; Nilsson-Remahl I. A. Functional recovery in primates with brachial plexus injury after spinal cord implantation of avulsed ventral roots. J. Neurol. Neurosurg. Psychiatry, 1993, 56(6), 649-654.
61. Hoang T. X.; Pikov V.; Havton L. A. Functional reinnervation of the rat lower urinary tract after cauda equina injury and repair. J. Neurosci., 2006, 26(34), 8672-8679.
62. Hoke A.; Redett R.; Hameed H.; Jari R.; Zhou C.; Li Z. B.; Griffin J. W.; Brushart T. M. Schwann cells express motor and sensory phenotypes that regulate axon regeneration. J. Neurosci., 2006, 26(38), 9646-9655.
63. Nichols C. M.; Brenner M. J.; Fox I. K.; Tung T. H.; Hunter D. A.; Rickman S. R.; Mackinnon S. E. Effects of motor versus sensory nerve grafts on peripheral nerve regeneration. Exp. Neurol., 2004, 190(2), 347-355.
64. Chu T. H.; Du Y.; Wu W. Motor nerve graft is better than sensory nerve graft for survival and regeneration of motoneurons after spinal root avulsion in adult rats. Exp. Neurol., 2008, 212(2), 562-565.
65. Snider W. D.; Johnson E. M. Jr. Neurotrophic molecules. Ann. Neurol., 1989, 26(4), 489-506.
66. Barde Y. A. What, if anything, is a neurotrophic factor? Trends Neurosci., 1988, 11(8), 343-346.
67. Levi-Montalcini R.; Hamburger V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J. Exp. Zool., 1951, 116(2), 321-361.
68. Yin Q.; Kemp G. J.; Frostick S. P. Neurotrophins, neurones and peripheral nerve regeneration. J. Hand Surg., [Br. ], 1998, 23(4), 433-437.
69. Birch R. Surgery for Brachial Plexus Injury. J. Bone Joint Surg., 1993, 75B, 346-348.
70. Henderson C. E.; Camu W.; Mettling C.; Gouin A.; Poulsen K.; Karihaloo M.; Rullamas J.; Evans T.; McMahon S. B.; Armanini M. P. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature, 1993, 363(6426), 266-270.
71. Bocchini V.; Angeletti P. U. The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc. Natl. Acad. Sci. USA, 1969, 64(2), 787-794.
72. Heumann R.; Korsching S.; Scott J.; Thoenen H. Relationship between levels of nerve growth factor (NGF) and its messenger RNA in sympathetic ganglia and peripheral target tissues. EMBO J., 1984, 3(13), 3183-3189.
73. Korsching S.; Auburger G.; Heumann R.; Scott J.; Thoenen H. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J., 1985, 4(6), 1389-1393.
74. Chandler C. E.; Parsons L. M.; Hosang M.; Shooter E. M. A monoclonal antibody modulates the interaction of nerve growth factor with PC12 cells. J. Biol. Chem, 1984, 259(11), 6882-6889.
75. O'Brien R. J.; Fischbach G. D. Isolation of embryonic chick motoneurons and their survival in vitro. J. Neurosci., 1986, 6(11), 3265-3274.
76. Schaffner A. E.; St John P. A.; Barker J. L. Fluorescence-activated cell sorting of embryonic mouse and rat motoneurons and their long-term survival in vitro. J. Neurosci., 1987, 7(10), 3088-3104.
77. Korsching S. The neurotrophic factor concept: a reexamination. J. Neurosci., 1993, 73(7), 2739-2748.
78. Oppenheim R. W. Neurotrophic survival molecules for motoneurons: an embarrassment of riches. Neuron, 1996, 17(2), 195-197.
79. Barde Y. A. The nerve growth factor family. Prog. Growth Factor Res., 1990, 2(4), 237-248.
80. Arevalo J. C.; Wu S. H. Neurotrophin signaling: many exciting surprises! Cell Mol. Life Sci., 2006, 63(13), 1523-1537.
81. Hempstead B. L. Dissecting the diverse actions of pro- and mature neurotrophins. Curr. Alzheimer Res., 2006, 3(1), 19-24.
82. Chao M. V. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat. Rev. Neurosci., 2003, 4(4), 299-309.
83. Lu B.; Pang P. T.; Woo N. H. The yin and yang of neurotrophin action. Nat. Rev. Neurosci., 2005, 6(8), 603-614.
84. Boeshore K. L.; Luckey C. N.; Zigmond R. E.; Large T. H. TrkB isoforms with distinct neurotrophin specificities are expressed in predominantly nonoverlapping populations of avian dorsal root ganglion neurons. J. Neurosci., 1999, 19(12), 4739-4747.
85. Huang E. J.; Reichardt L. F. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem., 2003, 72, 609-642.
86. Josephson A.; Widenfalk J.; Trifunovski A.; Widmer H. R.; Olson L.; Spenger C. GDNF and NGF family members and receptors in human fetal and adult spinal cord and dorsal root ganglia. J. Comp. Neurol., 2001, 440(2), 204-217.
87. Koliatsos V. E.; Clatterbuck R. E.; Winslow J. W.; Cayouette M. H.; Price D. L. Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron, 1993, 70(3), 359-367.
88. Oppenheim R. W.; Yin Q. W.; Prevette D.; Yan Q. Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature, 1992, 360(6406), 755-757.
89. Sendtner M.; Holtmann B.; Kolbeck R.; Thoenen H.; Barde Y. A. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature, 1992, 360(6406), 757-759.
90. Boyd J. G.; Gordon T. Glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor sustain the axonal regeneration of chronically axotomized motoneurons in vivo. Exp. Neurol., 2003, 183(2), 610-619.
91. Novikov L.; Novikova L.; Kellerth J. O. Brain-derived neurotrophic factor promotes axonal regeneration and long-term survival of adult rat spinal motoneurons in vivo. Neuroscience, 1997, 79(3), 765-774
92. Streppel M.; Azzolin N.; Dohm S.; Guntinas-Lichius O.; Haas C.; Grothe C.; Wevers A.; Neiss W. F.; Angelov D. N. Focal application of neutralizing antibodies to soluble neurotrophic factors reduces collateral axonal branching after peripheral nerve lesion. Eur. J. Neurosci., 2002, 15(8), 1327-1342.
93. Zhang J. Y.; Luo X. G.; Xian C. J.; Liu Z. H.; Zhou X. F. Endogenous BDNF is required for myelination and regeneration of injured sciatic nerve in rodents. Eur. J. Neurosci., 2000, 12(12), 4171-4180.
94. Wu W.; Li L.; Yick L. W.; Chai H.; Xie Y.; Yang Y.; Prevette D. M.; Oppenheim R. W. GDNF and BDNF alter the expression of neuronal NOS, c-Jun, and p75 and prevent motoneuron death following spinal root avulsion in adult rats. J. Neurotrauma, 2003, 20(6), 603-612.
95. Chai H.; Wu W.; So K. F.; Prevette D. M.; Oppenheim R. W. Long-term effects of a single dose of brain-derived neurotrophic factor on motoneuron survival following spinal root avulsion in the adult rat. Neurosci. Lett., 1999, 274(3), 147-150.
96. Boyd J. G.; Gordon T. A dose-dependent facilitation and inhibition of peripheral nerve regeneration by brain-derived neurotrophic factor. Eur. J. Neurosci., 2002, 15(4), 613-626.
97. Yamauchi J.; Chan J. R.; Shooter E. M. Neurotrophins regulate Schwann cell migration by activating divergent signaling pathways dependent on Rho GTPases. Proc. Natl. Acad. Sci. USA, 2004, 101(23), 8774-8779.
98. Yan Q.; Elliott J. L.; Matheson C.; Sun J.; Zhang L.; Mu X.; Rex K. L.; Snider W. D. Influences of neurotrophins on mammalian motoneurons in vivo. J. Neurobiol., 1993, 24(12), 1555-1577.
99. Li L.; Oppenheim R. W.; Lei M.; Houenou L. J. Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse. J. Neurobiol., 1994, 25(7), 759-766.
100. Koliatsos V. E.; Cayouette M. H.; Berkemeier L. R.; Clatterbuck R. E.; Price D. L.; Rosenthal A. Neurotrophin 4/5 is a trophic factor for mammalian facial motor neurons. Proc. Natl. Acad. Sci. USA, 1994, 97(8), 3304-3308.
101. English A. W.; Meador W.; Carrasco D. I. Neurotrophin-4/5 is required for the early growth of regenerating axons in peripheral nerves. Eur. J. Neurosci., 2005, 21(10), 2624-2634.
102. Simon M.; Porter R.; Brown R.; Coulton G. R.; Terenghi G. Effect of NT-4 and BDNF delivery to damaged sciatic nerves on pheno-typic recovery of fast and slow muscles fibres. Eur. J. Neurosci., 2003, 18(9), 2460-2466.
103. Corse A. M.; Bilak M. M.; Bilak S. R.; Lehar M.; Rothstein J. D.; Kuncl R. W. Preclinical testing of neuroprotective neurotrophic factors in a model of chronic motor neuron degeneration. Neurobiol. Dis., 1999, 6(5), 335-346.
104. Van Westerlaak M. G.; Bar P. R.; Cools A. R.; Joosten E. A. Malonate-induced cortico-motoneuron death is attenuated by NT-4, but not by BDNF or NT-3. Neuroreport, 2001, 12(7), 1355-1358.
105. Reichardt L. F. Neurotrophin-regulated signalling pathways. Philos. Trans. R. Soc. Lond B Biol. Sci., 2006, 361(1473), 1545-1564.
106. Derouet D.; Rousseau F.; Alfonsi F.; Froger J.; Hermann J.; Barbier F.; Perret D.; Diveu C.; Guillet C.; Preisser L.; Dumont A.; Barbado M.; Morel A.; deLapeyriere O.; Gascan H.; Chevalier S. Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor. Proc. Natl. Acad. Sci. USA, 2004, 101(14), 4827-4832.
107. Elson G. C.; Lelievre E.; Guillet C.; Chevalier S.; Plun-Favreau H.; Froger J.; Suard I.; de Coignac A. B.; Delneste Y.; Bonnefoy J. Y.; Gauchat J. F.; Gascan H. CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nat. Neurosci., 2000, 3(9), 867-872.
108. Sendtner M.; Carroll P.; Holtmann B.; Hughes R. A.; Thoenen H. Ciliary neurotrophic factor. J. Neurobiol., 1994, 25(11), 1436-1453.
109. Sendtner M.; Stockli K. A.; Thoenen H. Synthesis and localization of ciliary neurotrophic factor in the sciatic nerve of the adult rat after lesion and during regeneration. J. Cell Biol., 1992, 118(1), 139-148.
110. Friedman B.; Scherer S. S.; Rudge J. S.; Helgren M.; Morrisey D.; McClain J.; Wang D. Y.; Wiegand S. J.; Furth M. E.; Lindsay R. M. Regulation of ciliary neurotrophic factor expression in myelin- related Schwann cells in vivo. Neuron, 1992, 9(2), 295-305.
111. Masu Y.; Wolf E.; Holtmann B.; Sendtner M.; Brem G.; Thoenen H. Disruption of the CNTF gene results in motor neuron degeneration. Nature, 1993, 365(6441), 27-32.
112. Sendtner M.; Gotz R.; Holtmann B.; Thoenen H. Endogenous ciliary neurotrophic factor is a lesion factor for axotomized motoneurons in adult mice. J. Neurosci., 1997, 17(18), 6999-7006.
113. Schweizer U.; Gunnersen J.; Karch C.; Wiese S.; Holtmann B.; Takeda K.; Akira S.; Sendtner M. Conditional gene ablation of Stat3 reveals differential signaling requirements for survival of motoneurons during development and after nerve injury in the adult. J. Cell Biol., 2002, 156(2), 287-297.
114. Nishimune H.; Vasseur S.; Wiese S.; Birling M. C.; Holtmann B.; Sendtner M.; Iovanna J. L.; Henderson C. E. Reg-2 is a motoneuron neurotrophic factor and a signalling intermediate in the CNTF survival pathway. Nat. Cell Biol., 2000, 2(12), 906-914.
115. Sendtner M.; Kreutzberg G. W.; Thoenen H. Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature, 1990, 345(6274), 440-441.
116. English A. W. Cytokines, growth factors and sprouting at the neuromuscular junction. J. Neurocytol., 2003, 32(5-8), 943-960.
117. Thoenen H.; Sendtner M. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat. Neurosci., 2002, 5 (Suppl), 1046-1050.
118. Martinou J. C.; Martinou I.; Kato A. C. Cholinergic differentiation factor (CDF/LIF) promotes survival of isolated rat embryonic mo- toneurons in vitro. Neuron, 1992, 8(4), 737-744.
119. Finkelstein D. I.; Bartlett P. F.; Horne M. K.; Cheema S. S. Leukemia inhibitory factor is a myotrophic and neurotrophic agent that enhances the reinnervation of muscle in the rat. J. Neurosci. Res., 1996, 46(1), 122-128.
120. Gadient R. A.; Otten U. H. Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials. Prog. Neurobiol., 1997, 52(5), 379-390.
121. Streit W. J.; Hurley S. D.; McGraw T. S.; Semple-Rowland S. L. Comparative evaluation of cytokine profiles and reactive gliosis supports a critical role for interleukin-6 in neuron-glia signaling during regeneration. J. Neurosci. Res., 2000, 61(1), 10-20.
122. Hirota H.; Kiyama H.; Kishimoto T.; Taga T. Accelerated Nerve Regeneration in Mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma. J. Exp. Med., 1996, 183(6), 2627-2634.
123. Pennica D.; King K. L.; Shaw K. J.; Luis E.; Rullamas J.; Luoh S. M.; Darbonne W. C.; Knutzon D. S.; Yen R.; Chien K. R. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natl. Acad. Sci. USA, 1995, 92(4), 1142-1146.
124. Pennica D.; Arce V.; Swanson T. A.; Vejsada R.; Pollock R. A.; Armanini M.; Dudley K.; Phillips H. S.; Rosenthal A.; Kato A. C.; Henderson C. E. Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons. Neuron, 1996, 17(1), 63-74.
125. Oppenheim R. W.; Wiese S.; Prevette D.; Armanini M.; Wang S.; Houenou L. J.; Holtmann B.; Gotz R.; Pennica D.; Sendtner M. Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons. J. Neurosci., 2001, 21(4), 1283-1291.
126. Robledo O.; Fourcin M.; Chevalier S.; Guillet C.; Auguste P.; Pouplard-Barthelaix A.; Pennica D.; Gascan H. Signaling of the cardiotrophin-1 receptor. Evidence for a third receptor component. J. Biol. Chem., 1997, 272(8), 4855-4863.
127. Zang D. W.; Cheema S. S. Leukemia inhibitory factor promotes recovery of locomotor function following spinal cord injury in the mouse. J. Neurotrauma, 2003, 20(11), 1215-1222.
128. Blesch A.; Uy H. S.; Grill R. J.; Cheng J. G.; Patterson P. H.; Tuszynski M. H. Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury. J. Neurosci., 1999, 19(9), 3556-3566.
129. Bottner M.; Krieglstein K.; Unsicker K. The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions. J. Neurochem., 2000, 75(6), 2227-2240.
130. Dhandapani K. M.; Brann D. W. Transforming growth factor-beta: a neuroprotective factor in cerebral ischemia. Cell Biochem. Biophys., 2003, 39(1), 13-22.
131. Wang P. Y.; Koishi K.; McGeachie A. B.; Kimber M.; Maclaughlin D. T.; Donahoe P. K.; McLennan I. S. Mullerian inhibiting substance acts as a motor neuron survival factor in vitro. Proc. Natl. Acad. Sci. USA, 2005, 102(45), 16421-16425.
132. Wang P. Y.; Koishi K.; McLennan I. S. BMP6 is axonally transported by motoneurons and supports their survival in vitro. Mol. Cell Neurosci., 2007, 34(4), 653-661
133. Airaksinen M. S.; Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci., 2002, 3(5), 383-394.
134. Trupp M.; Scott R.; Whittemore S. R.; Ibanez C. F. Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells. J. Biol. Chem., 1999, 274(30), 20885-20894.
135. Paratcha G.; Ledda F.; Ibanez C. F. The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell, 2003, 113(7), 867-879.
136. Lin L. F.; Doherty D. H.; Lile J. D.; Bektesh S.; Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopa- minergic neurons. Science, 1993, 260(5111), 1130-1132.
137. Henderson C. E.; Phillips H. S.; Pollock R. A.; Davies A. M.; Le-meulle C.; Armanini M.; Simmons L.; Moffet B.; Vandlen R. A.; Simpson LC [corrected to Simmons. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science, 1994, 266(5187), 1062-1064.
138. Baumgartner B. J.; Shine H. D. Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population. J. Neurosci., 1997, 17(17), 6504-6511.
139. Blits B.; Carlstedt T. P.; Ruitenberg M. J.; de Winter F.; Hermens W. T.; Dijkhuizen P. A.; Claasens J. W.; Eggers R.; van der Sluis R.; Tenenbaum L.; Boer G. J.; Verhaagen J. Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor. Exp. Neurol., 2004, 189(2), 303-316.
140. Fine E. G.; Decosterd I.; Papaloizos M.; Zurn A. D.; Aebischer P. GDNF and NGF released by synthetic guidance channels support sciatic nerve regeneration across a long gap. Eur. J. Neurosci., 2002, 15(4), 589-601.
141. Li L.; Wu W.; Lin L. F.; Lei M.; Oppenheim R. W.; Houenou L. J. Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA, 1995, 92(21), 9771-9775.
142. Zhou L. H.; Wu W. Survival of injured spinal motoneurons in adult rat upon treatment with glial cell line-derived neurotrophic factor at 2 weeks but not at 4 weeks after root avulsion. J. Neurotrauma, 2006, 23(6), 920-927.
143. Bergerot A.; Shortland P. J.; Anand P.; Hunt S. P.; Carlstedt T. Co- treatment with riluzole and GDNF is necessary for functional recovery after ventral root avulsion injury. Exp. Neurol., 2004, 187(2), 359-366.
144. Cohick W. S.; Clemmons D. R. The insulin-like growth factors. Annu. Rev. Physiol., 1993, 55131-153.
145. Streck R. D.; Wood T. L.; Hsu M. S.; Pintar J. E. Insulin-like growth factor I and II and insulin-like growth factor binding protein-2 RNAs are expressed in adjacent tissues within rat embryonic and fetal limbs. Dev. Biol., 1992, 151(2), 586-596.
146. Neff N. T.; Prevette D.; Houenou L. J.; Lewis M. E.; Glicksman M. A.; Yin Q. W.; Oppenheim R. W. Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival. J. Neurobiol., 1993, 24(12), 1578-1588.
147. Oppenheim R. W.; Prevette D.; Haverkamp L. J.; Houenou L.; Yin Q. W.; McManaman J. Biological studies of a putative avian muscle-derived neurotrophic factor that prevents naturally occurring motoneuron death in vivo. J. Neurobiol., 1993, 24(8), 1065-1079.
148. Vincent A. M.; Mobley B. C.; Hiller A.; Feldman E. L. IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiol. Dis., 2004, 16(2), 407-416.
149. Arakawa Y.; Sendtner M.; Thoenen H. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines. J. Neurosci., 1990, 10(11), 3507-3515.
150. Ang L. C.; Bhaumick B.; Munoz D. G.; Sass J.; Juurlink B. H. Effects of astrocytes, insulin and insulin-like growth factor I on the survival of motoneurons in vitro. J. Neurol. Sci., 1992, 109(2), 168-172.
151. Gehrmann J.; Yao D. L.; Bonetti B.; Bondy C. A.; Brenner M.; Zhou J.; Kreutzberg G. W.; Webster H. D. Expression of insulin-like growth factor-I and related peptides during motoneuron regeneration. Exp. Neurol., 1994, 128(2), 202-210.
152. Caroni P.; Grandes P. Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors. J. Cell Biol., 1990, 110(4), 1307-1317.
153. Near S. L.; Whalen L. R.; Miller J. A.; Ishii D. N. Insulin-like growth factor II stimulates motor nerve regeneration. Proc. Natl. Acad. Sci. USA, 1992, 89(24), 11716-11720.
154. Kanje M.; Skottner A.; Sjoberg J.; Lundborg G. Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve. Brain Res., 1989, 486(2), 396-398.
155. Ozdinler P. H.; Macklis J. D. IGF-I specifically enhances axon outgrowth of corticospinal motor neurons. Nat. Neurosci., 2006, 9(11), 1371-1381.
156. Haninec P.; Houst'ava L.; Stejskal L.; Dubovy P. Rescue of rat spinal motoneurons from avulsion-induced cell death by intrathecal administration of IGF-I and Cerebrolysin. Ann. Anat., 2003, 185(3), 233-238.
157. Ornitz D. M.; Itoh N. Fibroblast growth factors. Genome Biol., 2001, 2(3), REVIEWS3005-.
158. Itoh N.; Ornitz D. M. Evolution of the Fgf and Fgfr gene families. Trends Genet., 2004, 20(11), 563-569.
159. Haastert K.; Lipokatic E.; Fischer M.; Timmer M.; Grothe C. Differentially promoted peripheral nerve regeneration by grafted Schwann cells over-expressing different FGF-2 isoforms. Neurobiol. Dis., 2006, 27(1), 138-153.
160. Anderson K. J.; Dam D.; Lee S.; Cotman C. W. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature, 1988, 332(6162), 360-361.
161. Teng Y. D.; Mocchetti I.; Wrathall J. R. Basic and acidic fibroblast growth factors protect spinal motor neurones in vivo after experimental spinal cord injury. Eur. J. Neurosci., 1998, 10(2).
162. D.; Mocchetti I.; Taveira-DaSilva A. M.; Gillis R. A.; Wrathall J. R. Basic fibroblast growth factor increases long-term survival of spinal motor neurons and improves respiratory function after experimental spinal cord injury. J. Neurosci., 1999, 19(16), 7037-7047.
163. Florkiewicz R. Z.; Sommer A. Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. Proc. Natl. Acad. Sci. USA, 1989, 86(11), 3978-3981.
164. Meisinger C.; Grothe C. Differential regulation of fibroblast growth factor (FGF)-2 and FGF receptor 1 mRNAs and FGF-2 isoforms in spinal ganglia and sciatic nerve after peripheral nerve lesion. J. Neurochem., 1997, 68(3), 1150-1158.
165. Piehl F.; Hammarberg H.; Hokfelt T.; Cullheim S. Regulatory effects of trophic factors on expression and distribution of CGRP and GAP-43 in rat motoneurons. J. Neurosci. Res., 1998, 51(1), 1-14.
166. Gouin A.; Bloch-Gallego E.; Tanaka H.; Rosenthal A.; Henderson C. E. Transforming growth factor-beta 3, glial cell line-derived neurotrophic factor, and fibroblast growth factor-2, act in different manners to promote motoneuron survival in vitro. J. Neurosci. Res., 1996, 43(4), 454-464.
167. Pehar M.; Vargas M. R.; Cassina P.; Barbeito A. G.; Beckman J. S.; Barbeito L. Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis. Neurodegener. Dis., 2005, 2(3-4), 139-146.
168. Pehar M.; Cassina P.; Vargas M. R.; Castellanos R.; Viera L.; Beckman J. S.; Estevez A. G.; Barbeito L. Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J. Neurochem., 2004, 89(2), 464-473.
169. Vargas M. R.; Pehar M.; Cassina P.; Martinez-Palma L.; Thompson J. A.; Beckman J. S.; Barbeito L. Fibroblast growth factor-1 induces heme oxygenase-1 via nuclear factor erythroid 2-related factor 2 (Nrf2) in spinal cord astrocytes: consequences for motor neuron survival. J. Biol. Chem., 2005, 280(27), 25571-25579.
170. Chan K.; Han X. D.; Kan Y. W. An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc. Natl. Acad. Sci. USA, 2001, 98(8), 4611-4616.
171. Chan K.; Kan Y. W. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc. Natl. Acad. Sci. USA, 1999, 96(22), 12731-12736.
172. Laird J. M.; Mason G. S.; Thomas K. A.; Hargreaves R. J.; Hill R. G. Acidic fibroblast growth factor stimulates motor and sensory axon regeneration after sciatic nerve crush in the rat. Neuroscience, 1995, 65(1), 209-216.
173. Huang M. C.; Chen K. C.; Chuang T. Y.; Chang W. C.; Lee L. S.; Huang W. C.; Cheng H. Cervical root repair in adult rats after transection: recovery of forelimb motor function. Exp. Neurol., 2003, 180(2), 101-109.
174. Lin P. H.; Cheng H.; Huang W. C.; Chuang T. Y. Spinal cord implantation with acidic fibroblast growth factor as a treatment for root avulsion in obstetric brachial plexus palsy. J. Chin Med. Assoc., 2005, 68(8), 392-396.
175. Nakamura T.; Nishizawa T.; Hagiya M.; Seki T.; Shimonishi M.; Sugimura A.; Tashiro K.; Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature, 1989, 342(6248), 440-443.
176. Stoker M.; Gherardi E.; Perryman M.; Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature, 1987, 327(6119), 239-242.
177. Birchmeier C.; Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol., 1998, 8(10), 404-410.
178. Matsumoto K.; Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem. Biophys. Res. Commun., 1997, 239(3), 639-644.
179. Maina F.; Klein R. Hepatocyte growth factor, a versatile signal for developing neurons. Nat. Neurosci., 1999, 2(3), 213-217.
180. Matsumoto K.; Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J. Biochem., 1996, 119(4), 591-600.
181. Jung W.; Castren E.; Odenthal M.; Vande Woude G. F.; Ishii T.; Dienes H. P.; Lindholm D.; Schirmacher P. Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain. J. Cell Biol., 1994, 126(2), 485-494.
182. Yamagata T.; Muroya K.; Mukasa T.; Igarashi H.; Momoi M.; Tsukahara T.; Arahata K.; Kumagai H.; Momoi T. Hepatocyte growth factor specifically expressed in microglia activated Ras in the neurons, similar to the action of neurotrophic factors. Biochem. Biophys. Res. Commun., 1995, 210(1), 231-237.
183. Wong V.; Glass D. J.; Arriaga R.; Yancopoulos G. D.; Lindsay R. M.; Conn G. Hepatocyte growth factor promotes motor neuron survival and synergizes with ciliary neurotrophic factor. J. Biol. Chem., 1997, 272(8), 5187-5191.
184. Ebens A.; Brose K.; Leonardo E. D.; Hanson M. G. Jr.; Bladt F.; Birchmeier C.; Barres B. A.; Tessier-Lavigne M. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron, 1996, 17(6), 1157-1172.
185. Novak K. D.; Prevette D.; Wang S.; Gould T. W.; Oppenheim R. W. Hepatocyte growth factor/scatter factor is a neurotrophic survival factor for lumbar but not for other somatic motoneurons in the chick embryo. J. Neurosci., 2000, 20(1), 326-337.
186. Yamamoto Y.; Livet J.; Pollock R. A.; Garces A.; Arce V.; de- Lapeyriere O.; Henderson C. E. Hepatocyte growth factor (HGF/SF) is a muscle-derived survival factor for a subpopulation of embryonic motoneurons. Development, 1997, 124(15), 2903-2913.
187. Okura Y.; Arimoto H.; Tanuma N.; Matsumoto K.; Nakamura T.; Yamashima T.; Miyazawa T.; Matsumoto Y. Analysis of neurotrophic effects of hepatocyte growth factor in the adult hypoglossal nerve axotomy model. Eur. J. Neurosci., 1999, 11(11), 4139-4144.
188. Sun W.; Funakoshi H.; Nakamura T. Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J. Neurosci., 2002, 22(15), 6537-6548.
189. Hayashi Y.; Kawazoe Y.; Sakamoto T.; Ojima M.; Wang W.; Takazawa T.; Miyazawa D.; Ohya W.; Funakoshi H.; Nakamura T.; Watabe K. Adenoviral gene transfer of hepatocyte growth factor prevents death of injured adult motoneurons after peripheral nerve avulsion. Brain Res., 2006, 1111(1), 187-195.
190. Conn G.; Bayne M. L.; Soderman D. D.; Kwok P. W.; Sullivan K. A.; Palisi T. M.; Hope D. A.; Thomas K. A. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc. Natl. Acad. Sci. USA, 1990, 87(7), 2628-2632.
191. Ferrara N.; Leung D. W.; Cachianes G.; Winer J.; Henzel W. J. Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells. Methods Enzymol., 1991, 198, 391-405.
192. Ferrara N.; Henzel W. J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun., 1989, 161(2), 851-858.
193. Rosenthal R. A.; Megyesi J. F.; Henzel W. J.; Ferrara N.; Folkman J. Conditioned medium from mouse sarcoma 180 cells contains vascular endothelial growth factor. Growth Factors, 1990, 4(1), 53-59.
194. Thurston G.; Gale N. W. Vascular endothelial growth factor and other signaling pathways in developmental and pathologic angiogenesis. Int. J. Hematol., 2004, 80(1), 7-20.
195. Jin K. L.; Mao X. O.; Greenberg D. A. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc. Natl. Acad. Sci. USA, 2000, 97(18), 10242-10247.
196. Schratzberger P.; Schratzberger G.; Silver M.; Curry C.; Kearney M.; Magner M.; Alroy J.; Adelman L. S.; Weinberg D. H.; Ropper A. H.; Isner J. M. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat. Med., 2000, 6(4), 405-413.
197. Azzouz M.; Ralph G. S.; Storkebaum E.; Walmsley L. E.; Mitrophanous K. A.; Kingsman S. M.; Carmeliet P.; Mazarakis N. D. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature, 2004, 429(6990), 413-417.
198. Storkebaum E.; Lambrechts D.; Dewerchin M.; Moreno-Murciano M. P.; Appelmans S.; Oh H.; Van Damme P.; Rutten B.; Man W. Y.; De Mol M.; Wyns S.; Manka D.; Vermeulen K.; Van Den Bosch L.; Mertens N.; Schmitz C.; Robberecht W.; Conway E. M.; Collen D.; Moons L.; Carmeliet P. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci., 2005, 8(1), 85-92.
199. Ogunshola O. O.; Stewart W. B.; Mihalcik V.; Solli T.; Madri J. A.; Ment L. R. Neuronal VEGF expression correlates with angio-genesis in postnatal developing rat brain. Brain Res. Dev. Brain Res., 2000, 119(1), 139-153.
200. Bartholdi D.; Rubin B. P.; Schwab M. E. VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur. J. Neurosci., 1997, 9(12), 2549-2560.
201. Skold M.; Cullheim S.; Hammarberg H.; Piehl F.; Suneson A.; Lake S.; Sjogren A.; Walum E.; Risling M. Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration. Eur. J. Neurosci., 2000, 12(10), 3675-3686.
202. Thoenen H.; Sendtner M. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat. Neurosci., 2002, 5 (Suppl), 1046-1050.
203. Oosthuyse B.; Moons L.; Storkebaum E.; Beck H.; Nuyens D.; Brusselmans K.; Van Dorpe J.; Hellings P.; Gorselink M.; Heymans S.; Theilmeier G.; Dewerchin M.; Laudenbach V.; Vermylen P.; Raat H.; Acker T.; Vleminckx V.; Van Den Bosch L.; Cashman N.; Fujisawa H.; Drost M. R.; Sciot R.; Bruyninckx F.; Hicklin D. J.; Ince C.; Gressens P.; Lupu F.; Plate K. H.; Robberecht W.; Herbert J. M.; Collen D.; Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet., 2001, 28(2), 131-138.
204. Lambrechts D.; Storkebaum E.; Morimoto M.; Del-Favero J.; Desmet F.; Marklund S. L.; Wyns S.; Thijs V.; Andersson J.; van Marion, I; Al-Chalabi A.; Bornes S.; Musson R.; Hansen V.; Beckman L.; Adolfsson R.; Pall H. S.; Prats H.; Vermeire S.; Rut- geerts P.; Katayama S.; Awata T.; Leigh N.; Lang-Lazdunski L.; Dewerchin M.; Shaw C.; Moons L.; Vlietinck R.; Morrison K. E.; Robberecht W.; Van Broeckhoven C.; Collen D.; Andersen P. M.; Carmeliet P. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet., 2003, 34(4), 383-394.
205. Tolosa L.; Mir M.; Asensio V. J.; Olmos G.; Llado J. Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase. J. Neurochem., 2008; 105(4),1080-90.
206. Bogaert E.; Van Damme P.; Van Den Bosch L.; Robberecht W. Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases. Muscle Nerve, 2006, 34(4), 391-405.
207. Hobson M. I.; Green C. J.; Terenghi G. VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy. J. Anat., 2000, 197 (Pt 4), 591-605.
208. Law R. H.; Zhang Q.; McGowan S.; Buckle A. M.; Silverman G. A.; Wong W.; Rosado C. J.; Langendorf C. G.; Pike R. N.; Bird P. I.; Whisstock J. C. An overview of the serpin superfamily. Genome Biol., 2006, 7(5), 216.
209. Steele F. R.; Chader G. J.; Johnson L. V.; Tombran-Tink J. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc. Natl. Acad. Sci. USA, 1993, 90(4), 1526-1530.
210. Tombran-Tink J.; Chader G. G.; Johnson L. V. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp. Eye Res., 1991, 53(3), 411-414.
211. Tombran-Tink J.; Johnson L. V. Neuronal differentiation of retino-blastoma cells induced by medium conditioned by human RPE cells. Invest. Ophthalmol. Vis. Sci., 1989, 30(8), 1700-1707.
212. Monard D.; Niday E.; Limat A.; Solomon F. Inhibition of protease activity can lead to neurite extension in neuroblastoma cells. Prog. Brain Res., 1983, 58359-364.
213. Houenou L. J.; Turner P. L.; Li L.; Oppenheim R. W.; Festoff B. W. A serine protease inhibitor, protease nexin I, rescues motoneurons from naturally occurring and axotomy-induced cell death.P roc. Natl. Acad. Sci. USA, 1995, 92(3), 895-899.
214. Festoff B. W.; Nelson P. G.; Brenneman D. E. Prevention of activity-dependent neuronal death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting neurotrophic serpin, protease nexin I. J. Neurobiol., 1996, 30(2), 255-266.
215. Tombran-Tink J.; Mazuruk K.; Rodriguez I. R.; Chung D.; Linker T.; Englander E.; Chader G. J. Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol. Vis., 1996; 4, 2-11.
216. Tombran-Tink J.; Barnstable C. J. PEDF: a multifaceted neurotro- phic factor. Nat. Rev. Neurosci., 2003, 4(8), 628-636.
217. Bilak M. M.; Corse A. M.; Bilak S. R.; Lehar M.; Tombran-Tink J.; Kuncl R. W. Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. J. Neuropathol. Exp. Neurol., 1999, 58(7), 719-728.
218. Houenou L. J.; D'Costa A. P.; Li L.; Turgeon V. L.; Enyadike C.; Alberdi E.; Becerra S. P. Pigment epithelium-derived factor promotes the survival and differentiation of developing spinal motor neurons. J. Comp. Neurol., 1999, 412(3), 506-514.
219. Kuncl R. W.; Bilak M. M.; Bilak S. R.; Corse A. M.; Royal W.; Becerra S. P. Pigment epithelium-derived factor is elevated in CSF of patients with amyotrophic lateral sclerosis. J. Neurochem., 2002, 81(1), 178-184.
220. Bilak M. M.; Becerra S. P.; Vincent A. M.; Moss B. H.; Aymerich M. S.; Kuncl R. W. Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons. J. Neurosci., 2002, 22(21), 9378-9386.
221. Li Y. S.; Milner P. G.; Chauhan A. K.; Watson M. A.; Hoffman R. M.; Kodner C. M.; Milbrandt J.; Deuel T. F. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science, 1990, 250(4988), 1690-1694.
222. Li Y. S.; Hoffman R. M.; Le Beau M. M.; Espinosa R. III; Jenkins N. A.; Gilbert D. J.; Copeland N. G.; Deuel T. F. Characterizationo f the human pleiotrophin gene. Promoter region and chromosomal localization. J. Biol. Chem., 1992, 267(36), 26011-26016.
223. Rauvala H. An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors. EMBO J., 1989, 8(10), 2933-2941.
224. Perez-Pinera P.; Chang Y.; Deuel T. F. Pleiotrophin, a multifunctional tumor promoter through induction of tumor angiogenesis, remodeling of the tumor microenvironment, and activation of stromal fibroblasts. Cell Cycle, 2007, 6(23), 2877-2883.
225. Muramatsu T. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J. Biochem., 2002, 132(3), 359-371.
226. Mi R.; Chen W.; Hoke A. Pleiotrophin is a neurotrophic factor for spinal motor neurons. Proc. Natl. Acad. Sci. USA, 2007, 104(11), 4664-4669.
227. Blondet B.; Carpentier G.; Lafdil F.; Courty J. Pleiotrophin cellular localization in nerve regeneration after peripheral nerve injury. J. Histochem. Cytochem., 2005, 53(8), 971-977.
228. Meng K.; Rodriguez-Pena A.; Dimitrov T.; Chen W.; Yamin M.; Noda M.; Deuel T. F. Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc. Natl. Acad. Sci. USA, 2000, 97(6), 2603-2608.
229. Raulo E.; Chernousov M. A.; Carey D. J.; Nolo R.; Rauvala H. Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3). J. Biol. Chem., 1994, 269(17), 12999-13004.
230. Stoica G. E.; Kuo A.; Aigner A.; Sunitha I.; Souttou B.; Malerczyk C.; Caughey D. J.; Wen D.; Karavanov A.; Riegel A. T.; Wellstein A. Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin. J. Biol. Chem., 2001, 276(20), 16772-16779.
231. Muramatsu H.; Zou K.; Sakaguchi N.; Ikematsu S.; Sakuma S.; Muramatsu T. LDL receptor-related protein as a component of the midkine receptor. Biochem. Biophys. Res. Commun., 2000, 270(3), 936-941.
232. Gordon T.; Sulaiman O.; Boyd J. G. Experimental strategies to promote functional recovery after peripheral nerve injuries. J. Peripher. Nerv. Syst., 2003, 8(4), 236-250.
233. Hoke A.; Gordon T.; Zochodne D. W.; Sulaiman O. A. A decline in glial cell-line-derived neurotrophic factor expression is associated with impaired regeneration after long-term Schwann cell denervation. Exp. Neurol., 2002, 173(1), 77-85.
234. Nogradi A.; Szabo A.; Pinter S.; Vrbova G. Delayed riluzole treatment is able to rescue injured rat spinal motoneurons. Neuroscience, 2007, 144(2), 431-438.
235. Hendriks W. T.; Eggers R.; Carlstedt T. P.; Zaldumbide A.; Tannemaat M. R.; Fallaux F. J.; Hoeben R. C.; Boer G. J.; Verhaagen J. Lentiviral vector-mediated reporter gene expression in avulsed spinal ventral root is short-term, but is prolonged using an immune "stealth" transgene. Restor. Neurol. Neurosci., 2007, 25(5-6), 585-599.
236. Abdellatif A. A.; Pelt J. L.; Benton R. L.; Howard R. M.; Tsoulfas P.; Ping P.; Xu X. M.; Whittemore S. R. Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems. J. Neurosci. Res., 2006, 84(3), 553-567.
237. Blesch A.; Tuszynski M. H. Transient growth factor delivery sustains regenerated axons after spinal cord injury. J. Neurosci., 2007, 27(39), 10535-10545.
238. Lang E. M.; Schlegel N.; Sendtner M.; Asan E. Effects of root replantation and neurotrophic factor treatment on long-term motoneuron survival and axonal regeneration after C7 spinal root avulsion. Exp. Neurol., 2005, 194(2), 341-354.
239. Garreta E.; Genove E.; Borros S.; Semino C. E. Osteogenic differentiation of mouse embryonic stem cells and mouse embryonic fibroblasts in a three-dimensional self-assembling peptide scaffold. Tissue Eng., 2006, 12(8), 2215-2227.
240. Guo J.; Su H.; Zeng Y.; Liang Y. X.; Wong W. M.; Ellis-Behnke R. G.; So K. F.; Wu W. Reknitting the injured spinal cord by self-assembling peptide nanofiber scaffold. Nanomedicine, 2007, 3(4), 311-321.
241. Lindholm T.; Skold M. K.; Suneson A.; Carlstedt T.; Cullheim S.; Risling M. Semaphorin and neuropilin expression in motoneurons after intraspinal motoneuron axotomy. Neuroreport, 2004, 15(4), 649-654.
242. Widenfalk J.; Widmer H. R.; Spenger C. GDNF, RET and GFRalpha-1-3 mRNA expression in the developing human spinal cord and ganglia. Neuroreport, 1999, 10(7), 1433-1439.